Vulvodynia is believed to arise from a mix of nerve irritation, inflammation, pelvic muscle tension, hormonal decline, and shifts in the vaginal microbiome.
 Even a mild infection or irritation can leave local nerve endings hypersensitive. Over time, this becomes “central sensitization,” where pain signals amplify within the spinal cord and brain.

Key features of vulvodynia:

  • Burning, rawness, or sharp pain at the vaginal opening or surrounding area.
  • Pain triggered by touch, clothing, sitting, or intercourse.
  • The skin usually looks normal on exam.
  • Symptoms can last for months or years without treatment.

Why a Layered Approach Works Better

Topical therapy calms local inflammation and nerve endings at the vestibule.
 LDN reduces neuroinflammation throughout the nervous system.
 Supplements like PEA, omega-3s, and magnesium support nerve repair and immune balance.
 Resilience & lifestyle tools address the stress and tension that can amplify pain signals.
 Together, these layers target both the symptom (local pain) and the system (nerve, immune, hormonal, microbiome balance).

Evidence Highlights

  • Low-Dose Naltrexone (LDN): Small studies and case reports show benefit in chronic pelvic and vulvar pain by reducing microglial activation and central sensitization.
  • Topiramate (in topical form): Acts on sodium and glutamate channels to dampen abnormal nerve firing.
  • Diclofenac & Pentoxifylline: Decrease local prostaglandin activity and improve microcirculation, reducing inflammatory mediators.
  • Estriol / DHEA (topical hormones): Restore vaginal tissue integrity and may reduce pain in atrophic or post-menopausal vulvodynia.
  • PEA (Palmitoylethanolamide): Shown in multiple trials to reduce neuropathic pain intensity and improve quality of life.
  • Magnesium & Omega-3s: Support neuromuscular relaxation and anti-inflammatory signaling.
  • Probiotics / Microbiome balance: Emerging evidence links vaginal dysbiosis and chronic inflammation to pain persistence.

How Our Protocol Connects the Dots

By combining targeted topical therapy with systemic modulation (LDN), plus lifestyle and microbiome support, we treat vulvodynia as a multi-system pain disorder rather than a surface-level problem.